Regenerative Medicine for Acute Deafness
Recipient: FATE Therapeutics
Amount: $3,000,000
Location: Seattle, WA
This funding would use advanced stem cell research and developmental biology to develop therapeutic treatments for acute hearing loss among Army soldiers. This would advance safe and effective treatments for acute hearing loss, which affects many men and women of the Army on return home from war.
Fate Therapeutics, a company that has made some important leaps in producing induced stem cells without embryos or gene therapy.
No comments:
Post a Comment